Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.263
+0.004 (1.55%)
At close: Nov 4, 2024, 4:00 PM
0.256
-0.007 (-2.62%)
Pre-market: Nov 5, 2024, 5:32 AM EST
Lyra Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 31.91 | 22.35 | 32.55 | 45.75 | 74.59 | 9.81 | Upgrade
|
| Short-Term Investments | 35.59 | 80.4 | 65.34 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 67.5 | 102.75 | 97.89 | 45.75 | 74.59 | 9.81 | Upgrade
|
| Cash Growth | -41.89% | 4.96% | 113.99% | -38.67% | 660.53% | -58.94% | Upgrade
|
| Prepaid Expenses | 1.94 | 2.07 | 2.94 | 2.17 | 1.32 | 0.31 | Upgrade
|
| Total Current Assets | 69.44 | 104.82 | 100.83 | 47.92 | 75.92 | 10.12 | Upgrade
|
| Property, Plant & Equipment | 23.16 | 35.28 | 4.47 | 5.86 | 4.47 | 3.42 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 1.1 | Upgrade
|
| Other Long-Term Assets | 1.99 | 2.5 | 4.67 | 1.09 | 0.45 | 0.33 | Upgrade
|
| Total Assets | 94.58 | 142.6 | 109.97 | 54.87 | 80.83 | 14.96 | Upgrade
|
| Accounts Payable | 4.97 | 3.13 | 2.62 | 3.13 | 0.92 | 1.07 | Upgrade
|
| Accrued Expenses | 6.1 | 8.14 | 8.37 | 3.63 | 2.83 | 3.13 | Upgrade
|
| Current Portion of Leases | 4.27 | 5.43 | 1.55 | 1.07 | 0.99 | 0.9 | Upgrade
|
| Current Unearned Revenue | 0.81 | 1.66 | 1.28 | 9.79 | - | - | Upgrade
|
| Other Current Liabilities | 3.13 | 1.23 | 0.66 | 0.63 | 0.15 | 0.11 | Upgrade
|
| Total Current Liabilities | 19.28 | 19.6 | 14.47 | 18.25 | 4.88 | 5.21 | Upgrade
|
| Long-Term Leases | 32.48 | 21.45 | 0.67 | 0.38 | 1.45 | 2.43 | Upgrade
|
| Long-Term Unearned Revenue | 11.85 | 12.14 | 14.08 | 1.93 | - | - | Upgrade
|
| Total Liabilities | 63.61 | 53.18 | 29.21 | 20.55 | 6.34 | 7.64 | Upgrade
|
| Common Stock | 0.07 | 0.06 | 0.03 | 0.01 | 0.01 | - | Upgrade
|
| Additional Paid-In Capital | 412.85 | 400.69 | 329.39 | 227.7 | 224.36 | 4.42 | Upgrade
|
| Retained Earnings | -381.94 | -311.36 | -248.68 | -193.4 | -149.88 | -127.76 | Upgrade
|
| Comprehensive Income & Other | -0 | 0.03 | 0.01 | - | - | - | Upgrade
|
| Total Common Equity | 30.98 | 89.42 | 80.75 | 34.32 | 74.49 | -123.34 | Upgrade
|
| Shareholders' Equity | 30.98 | 89.42 | 80.75 | 34.32 | 74.49 | 7.33 | Upgrade
|
| Total Liabilities & Equity | 94.58 | 142.6 | 109.97 | 54.87 | 80.83 | 14.96 | Upgrade
|
| Total Debt | 36.75 | 26.88 | 2.22 | 1.45 | 2.44 | 3.33 | Upgrade
|
| Net Cash (Debt) | 30.75 | 75.87 | 95.68 | 44.29 | 72.15 | 6.48 | Upgrade
|
| Net Cash Growth | -73.14% | -20.70% | 116.01% | -38.61% | 1013.14% | -72.87% | Upgrade
|
| Net Cash Per Share | 0.50 | 1.52 | 3.16 | 3.41 | 8.40 | 32.07 | Upgrade
|
| Filing Date Shares Outstanding | 65.46 | 59.74 | 31.83 | 13.01 | 12.95 | 0.23 | Upgrade
|
| Total Common Shares Outstanding | 65.46 | 57.21 | 31.83 | 13.01 | 12.93 | 0.23 | Upgrade
|
| Working Capital | 50.16 | 85.22 | 86.36 | 29.67 | 71.03 | 4.91 | Upgrade
|
| Book Value Per Share | 0.47 | 1.56 | 2.54 | 2.64 | 5.76 | -534.17 | Upgrade
|
| Tangible Book Value | 30.98 | 89.42 | 80.75 | 34.32 | 74.49 | -123.34 | Upgrade
|
| Tangible Book Value Per Share | 0.47 | 1.56 | 2.54 | 2.64 | 5.76 | -534.17 | Upgrade
|
| Machinery | 5.1 | 3.4 | 5.35 | 5.59 | 3.58 | 2.02 | Upgrade
|
| Construction In Progress | - | - | - | - | 0.5 | 0.14 | Upgrade
|
| Leasehold Improvements | 0.49 | 0.46 | 0.4 | 2.11 | 0.32 | 0.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.